...
首页> 外文期刊>International journal of oncology >Modulation of the cancer cell transcriptome by culture media formulations and cell density
【24h】

Modulation of the cancer cell transcriptome by culture media formulations and cell density

机译:通过培养基配方和细胞密度调节癌细胞转录组

获取原文
           

摘要

We investigated how varying the composition of cell culture formulations and growing cancer cells at different densities might affect tumor cell genotype. Specifically, we compared gene expression profiles generated by human MDA?MB?231 breast cancer cells cultured in different media?[minimum essential medium?(MEM), Dulbecco's modified Eagle's medium?(DMEM), or Roswell Park Memorial Institute?(RPMI)?1640 medium] containing different concentrations of fetal bovine serum?(FBS) or different sera?(equine or bovine) that were grown at different cell densities. More than 2,000?genes were differentially modulated by at least a 2?fold difference when MDA?MB?231 cancer cells were 90% confluent and compared with cultures that were 50% confluent. Altering the concentration of serum produced an even more pronounced effect on MDA?MB?231 cancer cell gene expression in that 2,981?genes were differentially expressed in a comparison between cells cultured in 0.1% FBS and same cell density cultures that were maintained in 10% FBS. A comparison between MDA?MB?231 cancer cells that were 90% confluent in MEM, DMEM, or RPMI?1640 media, all containing 10% FBS, resulted in 8,925 differentially expressed genes. Moreover, one?quarter?(25.6%) of genes from our genome?wide expression analysis were expressed at significantly different levels by cells grown in MEM, DMEM, or RPMI?1640 media. Genes associated with epithelial?mes-enchymal transition?(EMT) were among the genes that were differentially modulated by cells grown in different cell culture formulations and these genes were verified at the protein level. Collectively, these results underscore the importance of accurate reporting and maintenance of uniform culture conditions to ensure reproducible results.
机译:我们研究了如何改变细胞培养制剂的组成以及以不同密度生长的癌细胞可能如何影响肿瘤细胞的基因型。具体来说,我们比较了由人MDA?MB?231乳腺癌细胞在不同培养基([最小必需培养基](MEM),Dulbecco改良的Eagle's培养基?(DMEM)或Roswell Park Memorial Institute?(RPMI))中培养的基因表达谱。 [1640培养基]含有不同浓度的胎牛血清(FBS)或不同的血清(马或牛),它们在不同的细胞密度下生长。当MDA?MB?231癌细胞达到90%融合时,与超过50%融合的培养物相比,有2,000多个基因被差异化了至少2倍的差异。改变血清浓度对MDA?MB?231癌细胞基因表达产生了更为显着的影响,因为在0.1%FBS中培养的细胞与维持在10%中的相同细胞密度培养物之间的比较中差异表达了2,981?基因。 FBS。比较在90%的MEM,DMEM或RPMI?1640培养基中均含有10%FBS的MDA?MB?231癌细胞,它们产生了8,925个差异表达的基因。此外,在MEM,DMEM或RPMI?1640培养基中生长的细胞表达的基因组全基因组表达分析的四分之一(25.6%)基因以明显不同的水平表达。与上皮细胞-间质转化(EMT)相关的基因是在不同细胞培养配方中生长的细胞差异调节的基因之一,这些基因在蛋白质水平上得到了验证。总体而言,这些结果强调了准确报告和维持统一培养条件以确保可重复结果的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号